Skip to main content

Find Clinical Trials

Home
Conditions
Neoadjuvant Therapy

Clinical trial condition

Neoadjuvant Therapy

Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.

124 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Neoadjuvant Therapy trial results

Not yet recruiting

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

NCT06539377

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer

NCT06404463

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

NCT06404736

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +7 more
Locations: Zhimin Shao Shanghai, Not US/Canada, China

View Trial Details

Not yet recruiting

PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma

NCT06125223

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

NCT05996484

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

NCT05993858

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hebei, China

View Trial Details

Not yet recruiting

Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer

NCT05983094

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Enrolling by invitation

Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）

NCT06910072

Conditions: Breast Diseases, Breast Neoplasms, Neoadjuvant Therapy, +6 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Enrolling by invitation

Adaptive Neoadjuvant Therapy for Esophageal Cancer

NCT06990178

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +8 more
Locations: 113 Baohe Road,Longgang District,Shenzhen,China Shenzhen, Guangdong, China

View Trial Details

Active, not recruiting

Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

NCT05165225

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details